Two domains, one secure node. Complex medications and the 2026 innovation pipeline — and the whole of UK adult care: safeguarding, the law, the systems that move people safely, and the technology reshaping it. No jargon. No cookies. No personal data.
Everyday tablets to living-cell biologics, engineered cells and gene edits. Tap any block to expand how it works, what it treats and why it is complex to handle.
Large molecules grown in living cells, not chemically made.
Molecular-scale precision — the biggest new drug class.
Instructions that make your own cells build a protein.
A patient's own immune cells, re-engineered to hunt cancer.
Delivering functional genes to fix disease at the source.
Metabolic medicines moving from single to multi-target.
A guided missile: an antibody carrying a chemo payload.
One molecule that grabs two targets at once.
Silencing a faulty gene before it makes a harmful protein.
A targeting molecule that carries radiation to the tumour.
Taking the brakes off the immune system to fight cancer.
A single depot dose released slowly over weeks or months.
A live-style ledger of recent approvals and near-term breakthroughs, cross-checked against MHRA, NICE and FDA reporting. Each entry is a block in the innovation chain.
A BLyS-specific inhibitor approved to reduce proteinuria in adults with primary IgA nephropathy at risk of progression — a new option for a hard-to-treat kidney disease.
first-in-classA precision allogeneic cell therapy for stem-cell transplant in adults with blood cancers, designed to improve survival free of chronic graft-versus-host disease.
cell therapyAn IGF-1 receptor inhibitor for thyroid eye disease, expanding the targeted biologic toolkit for autoimmune-driven conditions.
IGF-1RHigh-dose semaglutide (7.2mg) approved for weight reduction, after the first oral GLP-1 for weight loss in Dec 2025. CagriSema filed on Phase III data showing up to 22.7% weight loss.
metabolicAn oral therapy with FDA Breakthrough Therapy designation — positioned as the first targeted option deployed immediately on detection of an ESR1 mutation.
breakthroughA streamlined UK route running NICE appraisal alongside MHRA licensing — bringing some new medicines to patients three to six months sooner. 27 companies signed as early adopters; first guidance expected June 2026.
UK accessA one-time treatment that edits a patient's own blood stem cells to treat sickle cell disease and transfusion-dependent beta-thalassaemia — the first licensed CRISPR medicine, moving through NHS access.
CRISPRAnti-amyloid antibodies that modestly slow early Alzheimer's disease. MHRA-licensed, but NICE has so far not recommended routine NHS funding on cost-effectiveness grounds — licensing outpacing access.
anti-amyloidA long-acting capsid inhibitor given roughly twice a year, showing very high efficacy as pre-exposure prophylaxis — a potential step-change in HIV prevention and adherence.
long-actingNot just medicines. An interactive field guide to adult health and social care in the UK — the settings, the safeguarding principles, the laws that protect people, the systems that move them safely through care, and the technology reshaping all of it.
The places that make up adult social care.
Trained, competency-assessed people working to clear plans.
Independent oversight in all four nations.
Adult safeguarding in England runs on six principles set out under the Care Act 2014 — short, sharp and worth knowing by heart.
People making their own decisions, with informed consent.
It is better to act before harm occurs.
The least intrusive response appropriate to the risk.
Support and representation for those in greatest need.
Local solutions through services working with communities.
Transparency in delivering safeguarding.
Every decision under the Care Act must promote the person's wellbeing — dignity and respect, control over daily life, protection from abuse and neglect, physical and mental health, suitable living conditions, and participation in work, education and family life. Wellbeing is not a bonus. It is the legal starting point.
The statutory framework behind every shift — beyond medicines. Tap a card to expand.
One law that reset adult social care in England.
When a council must make safeguarding enquiries.
Know what you are looking for.
Five principles before anyone decides for you.
Care must never quietly become confinement.
Chosen in advance, used when it matters.
Nine protected characteristics, one duty to adjust.
Four articles every care worker touches daily.
When things go wrong, honesty is the law.
Confidential data has rules — and so does silence.
Advocacy is a legal duty, not a favour.
Outcomes led by the person, not the process.
How good care actually runs, day to day — assessment, escalation, records and infection control.
Assess people at home, not from a hospital bed.
Safe · Effective · Caring · Responsive · Well-led.
Prompting, assisting and administering differ.
Factual, timely, neutral — every time.
Situation · Background · Assessment · Recommendation.
Six vital signs, one early warning score.
The cheapest life-saving technology is soap.
Outcomes, not task lists.
The tools arriving next, and the digital safety that keeps care records private.
Triage support, documentation drafts, pattern spotting.
Falls detection and quiet reassurance — with consent.
Interoperability is a safety feature, not an IT project.
The paper daily log is retiring.
Telecare must cross to digital before the lines go silent.
Technology assists. People decide.
How care data moves safely between systems.
UK GDPR & the Data Protection Act 2018.
Zero cookies. Zero trackers. No personal data.
Where medication meets the care sector — the everyday systems that keep it safe.
The legislation and guidance behind safe medicines management. Tap to expand.
The same cryptography that guards care records, discharge summaries and this page — running live in your browser via the Web Crypto API. Nothing you type here leaves your device.
A hash is a one-way digital fingerprint: change one letter and the whole print changes. It is how systems spot tampered records without reading them.
Every secure page starts with this conversation — the five steps that happened before you could read this sentence.
Your browser lists the ciphers it supports.
The server proves its identity with a signed certificate.
Both sides agree a shared secret nobody watching can derive.
Each side confirms the handshake wasn't tampered with.
Everything from here is sealed with symmetric keys.
Code-rain canvas tuned to stay smooth on phones and desktops alike.
Fluid type, touch targets and a collapsing menu — optimised for every screen.
Hex grids, block-ledger visuals and glitch/decode motion throughout.
Web Crypto AES-GCM & SHA-256. Keys and text never leave the browser.
A rapid check drawn from the sections above. Instant feedback, zero data collected — the score lives and dies in this tab.